Technical Analysis for KNTE - Kinnate Biopharma Inc.

Grade Last Price % Change Price Change
C 2.55 -0.39% -0.01
KNTE closed down 0.39 percent on Monday, March 18, 2024, on 55 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Flat

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bearish? Reversal 0.00%
Earnings Movers Other 0.00%
Bullish Engulfing Bullish -0.39%
Bollinger Band Squeeze Range Contraction -0.39%
Narrow Range Bar Range Contraction -0.39%
BB Squeeze Started Range Contraction -0.39%
Narrow Range Bar Range Contraction 0.79%
Earnings Movers Other 0.79%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance about 15 hours ago
Possible NR7 about 16 hours ago
60 Minute Opening Range Breakout about 18 hours ago
Rose Above Previous Day's High about 18 hours ago
Rose Above 10 DMA about 18 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors for treating genomically defined cancers. The company's lead product candidate is KIN002787, which is a rapidly accelerated fibrosarcoma inhibitor that is in preclinical stage for the treatment of patients with lung cancer, melanoma, and other solid tumors. Its other products in preclinical stage include KIN003, which are small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors (FGFR)2 and FGFR3 genes; and small molecule research programs, including a Cyclin-Dependent Kinase 12 inhibitor in its KIN004 program. Kinnate Biopharma Inc. was founded in 2018 and is headquartered in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Solid Tumors Melanoma Lung Cancer Sarcoma Fibroblast Growth Factor Fibroblast Growth Factor Receptor Fibrosarcoma

Is KNTE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.185
52 Week Low 1.04
Average Volume 308,100
200-Day Moving Average 2.33
50-Day Moving Average 2.45
20-Day Moving Average 2.53
10-Day Moving Average 2.56
Average True Range 0.07
RSI (14) 56.14
ADX 23.19
+DI 22.60
-DI 13.82
Chandelier Exit (Long, 3 ATRs) 2.45
Chandelier Exit (Short, 3 ATRs) 2.45
Upper Bollinger Bands 2.63
Lower Bollinger Band 2.43
Percent B (%b) 0.61
BandWidth 7.55
MACD Line 0.04
MACD Signal Line 0.04
MACD Histogram -0.0045
Fundamentals Value
Market Cap 120.14 Million
Num Shares 47.1 Million
EPS -2.78
Price-to-Earnings (P/E) Ratio -0.92
Price-to-Sales 0.00
Price-to-Book 0.63
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.60
Resistance 3 (R3) 2.60 2.58 2.59
Resistance 2 (R2) 2.58 2.57 2.58 2.58
Resistance 1 (R1) 2.57 2.56 2.57 2.57 2.58
Pivot Point 2.55 2.55 2.55 2.55 2.55
Support 1 (S1) 2.54 2.54 2.54 2.54 2.52
Support 2 (S2) 2.52 2.53 2.52 2.52
Support 3 (S3) 2.51 2.52 2.51
Support 4 (S4) 2.51